Philip J. Vickers serves as Executive at Revance Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Philip J. Vickers has executed 9 insider transactions totaling $138.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 4, 2022 involved receiving (via award) 6,059 shares valued at $0.
Philip J. Vickers currently holds 29,722 shares of Revance Therapeutics, Inc. (RVNC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Philip J. Vickers has been a net buyer of RVNC stock. They have purchased $138.5K and sold $0 worth of shares.
Philip J. Vickers's most recent insider trade was on May 4, 2022, when they sold 6,059 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $8.35 |
| Discretionary |
| May 5, 2021 | RVNC | $0 | Award | 4,013 | $N/A | Discretionary |
| May 14, 2020 | RVNC | $0 | Award | 6,000 | $N/A | Discretionary |
| May 9, 2019 | RVNC | $0 | Award | 4,500 | $N/A | Discretionary |
| May 10, 2018 | RVNC | $0 | Award | 3,000 | $N/A | Discretionary |
| Mar 16, 2018 | RVNC | $70.3K | Purchase | 2,250 | $31.25 | Discretionary |
| Mar 16, 2018 | RVNC | $28.1K | Purchase | 900 | $31.20 | Discretionary |
| May 11, 2017 | RVNC | $0 | Award | 3,000 | $N/A | Discretionary |